Cathepsin L1 Explained

Cathepsin L1 is a protein that in humans is encoded by the CTSL1 gene.[1] [2] [3] The protein is a cysteine cathepsin, a lysosomal cysteine protease that plays a major role in intracellular protein catabolism.[4] [5] [6] [7]

Function

Cathepsin L1 is a member of the Peptidase C1 (cathepsin) MEROPS family, which plays an important role in diverse processes including normal lysosome mediated protein turnover, antigen and proprotein processing, and apoptosis.[8] Its substrates include collagen and elastin, as well as alpha-1 protease inhibitor, a major controlling element of neutrophil elastase activity. The encoded protein has been implicated in several pathologic processes, including myofibril necrosis in myopathies and in myocardial ischemia, and in the renal tubular response to proteinuria. This protein, which is a member of the peptidase C1 family, is a dimer composed of disulfide-linked heavy and light chains, both produced from a single protein precursor. At least two transcript variants encoding the same protein have been found for this gene.[3]

Viral entry

Cleavage of the SARS-CoV-2 S2 spike protein required for viral entry into cells can be accomplished by proteases TMPRSS2 located on the cell membrane, or by cathepsins (primarily cathepsin L) in endolysosomes.[9] Hydroxychloroquine inhibits the action of cathepsin L in endolysosomes, but because cathepsin L cleavage is minor compared to TMPRSS2 cleavage, hydroxychloroquine does little to inhibit SARS-CoV-2 infection.

Inflammation

Although Cathepsin L is usually characterized as a lysosomal protease, it can be secreted, resulting in pathological inflammation.[10] Cathepsin L and other cysteine cathepsins tend to be secreted by macrophages and other tissue-invading immune cells when causing pathological inflammation.[11]

Interactions

CTSL1 has been shown to interact with Cystatin A.[12] [13]

Distribution

Cathepsin L has been reported in many organisms including fish,[14] birds, mammals, and sponges.[15]

See also

Further reading

External links

Notes and References

  1. Chauhan SS, Popescu NC, Ray D, Fleischmann R, Gottesman MM, Troen BR . Michael M. Gottesman . Cloning, genomic organization, and chromosomal localization of human cathepsin L . J Biol Chem . 268 . 2 . 1039–45 . Feb 1993 . 10.1016/S0021-9258(18)54038-2 . 8419312 . free .
  2. Joseph LJ, Chang LC, Stamenkovich D, Sukhatme VP . Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts . J Clin Invest . 81 . 5 . 1621–9 . Jun 1988 . 2835398 . 442598 . 10.1172/JCI113497 .
  3. Web site: Entrez Gene: CTSL1 cathepsin L1.
  4. Book: Barrett AJ, Kirschke H . Cathepsin B, cathepsin H, and cathepsin L . Proteolytic Enzymes, Part C . Methods in Enzymology . 80 Pt C . 535–561 . 1981 . 7043200 . 10.1016/s0076-6879(81)80043-2 . 9780121819804 .
  5. Lysosomal cysteine proteinases . Barrett AJ, Buttle DJ, Mason RW . ISI Atlas of Science. Biochemistry . 1988 . 1 . 256–260 .
  6. Joseph LJ, Chang LC, Stamenkovich D, Sukhatme VP . Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts . The Journal of Clinical Investigation . 81 . 5 . 1621–1629 . May 1988 . 2835398 . 442598 . 10.1172/JCI113497 .
  7. Kirschke H, Wikstrom P, Shaw E . Active center differences between cathepsins L and B: the S1 binding region . FEBS Letters . 228 . 1 . 128–130 . February 1988 . 3342870 . 10.1016/0014-5793(88)80600-8 . free . 1988FEBSL.228..128K .
  8. Dickinson DP . Cysteine Peptidases of Mammals: Their Biological Roles and Potential Effects in the Oral Cavity and Other Tissues in Health and Disease . Critical Reviews in Oral Biology and Medicine . 13 . 3 . 238–75 . 2002 . 12090464 . 10.1177/154411130201300304 .
  9. Jackson CB, Farzan M, Chen B, Choe H . Mechanisms of SARS-CoV-2 entry into cells . Nature Reviews. Molecular Cell Biology . 23 . 1 . 3–20 . January 2022 . 34611326 . 8491763 . 10.1038/s41580-021-00418-x .
  10. Gomes CP, Fernandes DE, Casimiro F, da Mata GF, Passos MT, Varela P, Mastroianni-Kirsztajn G, Pesquero JB . 6 . Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics . Frontiers in Cellular and Infection Microbiology . 10 . 589505 . 2022 . 33364201 . 7753008 . 10.3389/fcimb.2020.589505 . free .
  11. Berdowska I, Matusiewicz M . Cathepsin L, transmembrane peptidase/serine subfamily member 2/4, and other host proteases in COVID-19 pathogenesis - with impact on gastrointestinal tract . World Journal of Gastroenterology . 27 . 39 . 6590–6600 . October 2021 . 34754154 . 8554394 . 10.3748/wjg.v27.i39.6590 . free .
  12. 10.1016/S0003-9861(03)00319-9 . Majerle . Andreja . Jerala Roman . Sep 2003 . Protein inhibitors form complexes with procathepsin L and augment cleavage of the propeptide . Arch. Biochem. Biophys. . 417 . 1 . 53–8 . 0003-9861. 12921779 .
  13. Estrada . S . Nycander M. Hill N J. Craven C J. Waltho J P. Björk I . May 1998 . The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L . Biochemistry . 37 . 20 . 7551–60 . 0006-2960. 9585570 . 10.1021/bi980026r .
  14. A murrel cysteine protease, cathepsin L: bioinformatics characterization, gene expression and proteolytic activity . Venkatesh K, Prasanth B, Rajesh P, Annie JG, Mukesh P, Jesu A . Biologia . 2014 . 39 . 3 . 395–406 . 10.2478/s11756-013-0326-8. free . 2014Biolg..69..395K .
  15. Sevenich L, Pennacchio LA, Peters C, Reinheckel T . Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice . Biological Chemistry . 387 . 7 . 885–91 . July 2006 . 16913838 . 10.1515/BC.2006.112 . 27739485 .